SAFETY PROFILE OF SUBCUTANEOUS ABATACEPT FOCUSING ON CLINICALLY RELEVANT EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND UP TO 4.5 YEARS OF EXPOSURE Annual Meeting of the British-Society-for-Rheumatology Alten, R., Kaine, J. L., Keystone, E., Nash, P. T., Delaet, I., Qi, K., Genovese, M. C. OXFORD UNIV PRESS. 2012: 127–128

View details for Web of Science ID 000302487900350